Noah

Giveaway for our upcoming X Space with Lucent. $1,000 USDC for 10 winners - $100 each. To enter: • like • repost • follow @UseLucentHQ • reply with one biopharma theme, catalyst, or company you wish investors could track more clearly GLP-1s, oncology, rare disease, gene therapy, longevity, radiopharma, AI drug discovery, FDA catalysts - all fair. Lucent is building AI-native biopharma intelligence for one of the hardest markets to read. Bring a sharp question before the Space. Winners will be contacted within 7 days after the Space.

X Space - Thursday, May 28, 5PM UTC AX1 is partnering with @UseLucentHQ Lucent is an Alliance alum building in one of the harder corners of investing: biopharma. Join us with @JulianMalinak, co-founder of Lucent, to discuss why biopharma may need a much better investing interface. This market moves on FDA decisions, trial readouts, filings, expert debates, and small signals most investors never learn how to read. A lot of the information is technically public, but public does not mean understandable. It is scattered and hard to turn into a view before the market already reacts. Lucent is building for that gap. AI-native biopharma intelligence that helps investors track catalysts, understand company and asset-level context, and see why a signal may matter. Set a reminder. xitter.gq/i/spaces/1DGleeeQdmRJL